
### [MONDO:0016635](http://purl.obolibrary.org/obo/MONDO_0016635)
**Label:** rare thrombotic disorder due to a platelet anomaly

**Subclasses:** [MONDO:0011173](http://purl.obolibrary.org/obo/MONDO_0011173) (thrombocythemia 2), [MONDO:0005029](http://purl.obolibrary.org/obo/MONDO_0005029) (essential thrombocythemia), [MONDO:0013794](http://purl.obolibrary.org/obo/MONDO_0013794) (thrombocythemia 3), [MONDO:0018896](http://purl.obolibrary.org/obo/MONDO_0018896) (thrombotic thrombocytopenic purpura), [MONDO:0019111](http://purl.obolibrary.org/obo/MONDO_0019111) (familial thrombocytosis), [MONDO:0008554](http://purl.obolibrary.org/obo/MONDO_0008554) (thrombocythemia 1), [MONDO:0016636](http://purl.obolibrary.org/obo/MONDO_0016636) (rare thrombotic disorder due to a constitutional platelet anomaly), [MONDO:0016637](http://purl.obolibrary.org/obo/MONDO_0016637) (rare thrombotic disorder due to an acquired platelet anomaly), 

**Corr. equiv. classes:** [OMIM:614521](http://purl.obolibrary.org/obo/OMIM_614521), [OMIM:187950](http://purl.obolibrary.org/obo/OMIM_187950), [Orphanet:3318](http://www.orpha.net/ORDO/Orphanet_3318), [Orphanet:248404](http://www.orpha.net/ORDO/Orphanet_248404), [Orphanet:248401](http://www.orpha.net/ORDO/Orphanet_248401), [OMIM:601977](http://purl.obolibrary.org/obo/OMIM_601977), [Orphanet:71493](http://www.orpha.net/ORDO/Orphanet_71493), [Orphanet:54057](http://www.orpha.net/ORDO/Orphanet_54057), 

**Class expressions from DL-Learner:**

- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0001894](http://purl.obolibrary.org/obo/HP_0001894) (Thrombocytosis) 68.75%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0001894](http://purl.obolibrary.org/obo/HP_0001894) (Thrombocytosis) 68.75%
- [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 62.50%
- [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0100749](http://purl.obolibrary.org/obo/HP_0100749) (Chest pain) 62.50%
- [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0100545](http://purl.obolibrary.org/obo/HP_0100545) (Arterial stenosis) 62.50%
- [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 62.50%
- [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 62.50%
- [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) 62.50%
- [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) 62.50%
- [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0009145](http://purl.obolibrary.org/obo/HP_0009145) (Abnormal cerebral artery morphology) 62.50%
- [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) and [HP:0009121](http://purl.obolibrary.org/obo/HP_0009121) (Abnormal axial skeleton morphology) 62.50%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) 62.50%
- [HP:0003401](http://purl.obolibrary.org/obo/HP_0003401) (Paresthesia) and [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) 62.50%
- [HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly) and [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) 62.50%
- [HP:0002863](http://purl.obolibrary.org/obo/HP_0002863) (Myelodysplasia) and [HP:0004420](http://purl.obolibrary.org/obo/HP_0004420) (Arterial thrombosis) 62.50%


